Search Results - "Sidana, S"

Extended nasolabial flap in oral submucous fibrosis - our modification by Sidana, S.

“…Nasolabial Flaps are the most popular and commonly used flap in reconstructing mucosal defect left by fibrous band excision in developing countries like India…”
Get full text

Revisiting conditioning dose in newly diagnosed light chain amyloidosis undergoing frontline autologous stem cell transplant: impact on response and survival by Tandon, N, Muchtar, E, Sidana, S, Dispenzieri, A, Lacy, M Q, Dingli, D, Buadi, F K, Hayman, S R, Chakraborty, R, Hogan, W J, Gonsalves, W, Warsame, R, Kourelis, T V, Leung, N, Kapoor, P, Kumar, S K, Gertz, M A

“…Autologous stem cell transplantation (ASCT) is an important treatment modality in light chain (AL) amyloidosis. Use of reduced-dose melphalan conditioning is…”
Get full text

Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains by Sidana, S, Tandon, N, Dispenzieri, A, Gertz, M A, Buadi, F K, Lacy, M Q, Dingli, D, Fonder, A L, Hayman, S R, Hobbs, M A, Gonsalves, W I, Hwa, Y L, Kapoor, P, Kyle, R A, Leung, N, Go, R S, Lust, J A, Russell, S J, Zeldenrust, S R, Rajkumar, S V, Kumar, S K

“…Hematologic response criteria in light chain (AL) amyloidosis require the difference in involved and uninvolved free light chains (dFLC) to be at least 5…”
Get full text

Differential Diagnosis of Waldenström's Macroglobulinemia and Early Management: Perspectives from Clinical Practice by Cingam, Shashank, Sidana, Surbhi

“…Waldenström's Macroglobulinemia (WM) is a clonal B-lymphocyte neoplasm characterized by the presence of IgM monoclonal protein and ≥10% bone marrow involvement…”
Get full text

Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine by Molenaar, R J, Pleyer, C, Radivoyevitch, T, Sidana, S, Godley, A, Advani, A S, Gerds, A T, Carraway, H E, Kalaycio, M, Nazha, A, Adelstein, D J, Nasr, C, Angelini, D, Maciejewski, J P, Majhail, N, Sekeres, M A, Mukherjee, S

“…Exposure to ionizing radiation increases the risk of myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN), but such risks are not known in…”
Get full text

Re: Empty fenestration of the internal jugular vein: a rare phenomenon by Sidana, S, Ahuja, S

Get full text

P921: UPDATED EFFICACY AND SAFETY RESULTS OF TECLISTAMAB, A B‐CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC‐1 by Martínez‐López, J., Moreau, P., Usmani, S. Z., Garfall, A., Donk, N. W., San‐Miguel, J. F., Oriol, A., Chari, A., Karlin, L., Mateos, M.‐V., Popat, R., Nooka, A. K., Sidana, S., Trancucci, D., Verona, R., Girgis, S., Uhlar, C., Stephenson, T., Banerjee, A., Krishnan, A.

Get full text

P06: UPDATED RESULTS FROM THE PHASE 1/2 MAJESTEC‐1 STUDY OF TECLISTAMAB, A B‐CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA by Popat, R, Usmani, S, Garfall, A, Donk, N, Nahi, H, San‐Miguel, J, Oriol, A, Nooka, A, Martin, T, Rosinol, L, Chari, A, Karlin, L, Benboubker, L, Mateos, M, Bahlis, N, Moreau, P, Besemer, B, Martínez‐López, J, Sidana, S, Pei, L, Trancucci, D, Verona, R, Girgis, S, Olyslager, Y, Jaffe, M, Uhlar, C, Stephenson, T, Van Rampelbergh, R, Banerjee, A, Goldberg, J, Kobos, R, Krishnan, A

Get full text

Parapharyngeal ectopic thyroid mimicking deep lobe parotid tumour along with multinodular thyroid goitre--a very rare presentation by Sidana, S, Millet, B, Moss, C

Get full text

79 RISK OF MYELODYSPLASTIC SYNDROMES IN WELL-DIFFERENTIATED THYROID CANCERS TREATED WITH RADIOACTIVE IODINE by Pleyer, C, Sidana, S, Erik, O, Radivoyevitch, T, Advani, A.S, Gerds, A.T, Carraway, H, Kalaycio, M, Maciejewski, J.P, Sekeres, M.A, Mukherjee, S

Get full text

Teclistamab in Relapsed or Refractory Multiple Myeloma by Moreau, Philippe, Garfall, Alfred L., van de Donk, Niels W.C.J., Nahi, Hareth, San-Miguel, Jesús F., Oriol, Albert, Nooka, Ajay K., Martin, Thomas, Rosinol, Laura, Chari, Ajai, Karlin, Lionel, Benboubker, Lotfi, Mateos, Maria-Victoria, Bahlis, Nizar, Popat, Rakesh, Besemer, Britta, Martínez-López, Joaquín, Sidana, Surbhi, Delforge, Michel, Pei, Lixia, Trancucci, Danielle, Verona, Raluca, Girgis, Suzette, Lin, Shun X.W., Olyslager, Yunsi, Jaffe, Mindy, Uhlar, Clarissa, Stephenson, Tara, Van Rampelbergh, Rian, Banerjee, Arnob, Goldberg, Jenna D., Kobos, Rachel, Krishnan, Amrita, Usmani, Saad Z.

“…In this phase 1–2 study involving patients with relapsed or refractory myeloma, a bispecific antibody (teclistamab) that mediates T-cell activation and…”
Get full text

Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma by San-Miguel, Jesús, Dhakal, Binod, Yong, Kwee, Spencer, Andrew, Anguille, Sébastien, Mateos, María-Victoria, Fernández de Larrea, Carlos, Martínez-López, Joaquín, Moreau, Philippe, Touzeau, Cyrille, Leleu, Xavier, Avivi, Irit, Cavo, Michele, Ishida, Tadao, Kim, Seok Jin, Roeloffzen, Wilfried, van de Donk, Niels W.C.J., Dytfeld, Dominik, Sidana, Surbhi, Costa, Luciano J., Oriol, Albert, Popat, Rakesh, Khan, Abdullah M., Cohen, Yaël C., Ho, P. Joy, Griffin, James, Lendvai, Nikoletta, Lonardi, Carolina, Slaughter, Ana, Schecter, Jordan M., Jackson, Carolyn C., Connors, Kaitlyn, Li, Katherine, Zudaire, Enrique, Chen, Diana, Gilbert, Jane, Yeh, Tzu-min, Nagle, Sarah, Florendo, Erika, Pacaud, Lida, Patel, Nitin, Harrison, Simon J., Einsele, Hermann

“…Patients with lenalidomide-refractory disease who received ciltacabtagene autoleucel had significantly longer progression-free survival than those who received…”
Get full text

Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group by Moreau, Philippe, Kumar, Shaji K, San Miguel, Jesús, Davies, Faith, Zamagni, Elena, Bahlis, Nizar, Ludwig, Heinz, Mikhael, Joseph, Terpos, Evangelos, Schjesvold, Fredrik, Martin, Thomas, Yong, Kwee, Durie, Brian G M, Facon, Thierry, Jurczyszyn, Artur, Sidana, Surbhi, Raje, Noopur, van de Donk, Niels, Lonial, Sagar, Cavo, Michele, Kristinsson, Sigurdur Y, Lentzsch, Suzanne, Hajek, Roman, Anderson, Kenneth C, João, Cristina, Einsele, Hermann, Sonneveld, Pieter, Engelhardt, Monika, Fonseca, Rafael, Vangsted, Annette, Weisel, Katja, Baz, Rachid, Hungria, Vania, Berdeja, Jesus G, Leal da Costa, Fernando, Maiolino, Angelo, Waage, Anders, Vesole, David H, Ocio, Enrique M, Quach, Hang, Driessen, Christoph, Bladé, Joan, Leleu, Xavier, Riva, Eloisa, Bergsagel, Peter Leif, Hou, Jian, Chng, Wee Joo, Mellqvist, Ulf-Henrik, Dytfeld, Dominik, Harousseau, Jean-Luc, Goldschmidt, Hartmut, Laubach, Jacob, Munshi, Nikhil C, Gay, Francesca, Beksac, Meral, Costa, Luciano J, Kaiser, Martin, Hari, Parameswaran, Boccadoro, Mario, Usmani, Saad Z, Zweegman, Sonja, Holstein, Sarah, Sezer, Orhan, Harrison, Simon, Nahi, Hareth, Cook, Gordon, Mateos, Maria-Victoria, Rajkumar, S Vincent, Dimopoulos, Meletios A, Richardson, Paul G

“…This Policy Review presents the International Myeloma Working Group's clinical practice recommendations for the treatment of relapsed and refractory multiple…”
Get full text

Alleviation of pain associated with immunization injections by Sidana, Shyam S

Get full text

Plain language summary of the MajesTEC-1 study of teclistamab for the treatment of people with relapsed or refractory multiple myeloma by Moreau, Philippe, van de Donk, Niels Wcj, Nahi, Hareth, Oriol, Albert, Nooka, Ajay K, Martin, Thomas, Rosinol, Laura, Karlin, Lionel, Benboubker, Lotfi, Mateos, Maria-Victoria, Popat, Rakesh, Martínez-López, Joaquín, Sidana, Surbhi, Delforge, Michel, Pei, Lixia, Trancucci, Danielle, Olyslager, Yunsi, Uhlar, Clarissa, Stephenson, Tara, Rampelbergh, Rian Van, Banerjee, Arnob, Kobos, Rachel, Usmani, Saad Z

“…This is a summary of a phase 1-2 clinical trial called MajesTEC-1. This trial tested the cancer drug teclistamab in people with relapsed or refractory multiple…”
Get full text

Updated Results from MajesTEC-1: Phase 1/2 Study of Teclistamab, a B-Cell Maturation Antigen x CD3 Bispecific Antibody, in Relapsed/Refractory Multiple Myeloma by Moreau, Philippe, Usmani, Saad Z., Garfall, Alfred L., van de Donk, Niels W.C.J., Nahi, Hareth, San-Miguel, Jesus, Oriol, Albert, Nooka, Ajay K., Martin, Thomas, Rosinol, Laura, Chari, Ajai, Karlin, Lionel, Benboubker, Lotfi, Mateos, Maria-Victoria, Bahlis, Nizar J., Popat, Rakesh, Besemer, Britta, Martínez-López, Joaquín, Sidana, Surbhi, Pei, Lixia, Trancucci, Danielle, Verona, Raluca I., Girgis, Suzette, Olyslager, Yunsi, Jaffe, Mindy, Uhlar, Clarissa M., Stephenson, Tara, Van Rampelbergh, Rian, Banerjee, Arnob, Goldberg, Jenna D., Kobos, Rachel, Krishnan, Amrita Y.

“…Introduction: Teclistamab (JNJ-64007957) is a T-cell redirecting, bispecific IgG4 antibody that targets both B-cell maturation antigen (BCMA) and CD3 receptors…”
Get full text

Using a Modified Delphi Panel to Estimate Health Service Utilization for Patients with Advanced and Non-Advanced Systemic Light Chain Amyloidosis by Gertz, Morie, Abonour, Rafat, Gibbs, Sarah N, Finkel, Muriel, Landau, Heather, Lentzsch, Suzanne, Lin, Grace, Mahindra, Anuj, Quock, Tiffany, Rosenbaum, Cara, Rosenzweig, Michael, Sidana, Surbhi, Tuchman, Sascha A, Witteles, Ronald, Yermilov, Irina, Broder, Michael S

“…Purpose: Patients with diagnosed with systemic light chain (AL) amyloidosis at advanced Mayo stages have greater morbidity and mortality than those diagnosed…”
Get full text

Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies by Thanarajasingam, Gita, Minasian, Lori M, Bhatnagar, Vishal, Cavalli, Franco, De Claro, R Angelo, Dueck, Amylou C, El-Galaly, Tarec C, Everest, Neil, Geissler, Jan, Gisselbrecht, Christian, Gormley, Nicole, Gribben, John, Horowitz, Mary, Ivy, S Percy, Jacobson, Caron A, Keating, Armand, Kluetz, Paul G, Kwong, Yok Lam, Little, Richard F, Matasar, Matthew J, Mateos, Maria-Victoria, McCullough, Kristen, Miller, Robert S, Mohty, Mohamad, Moreau, Philippe, Morton, Lindsay M, Nagai, Sumimasa, Nair, Abhilasha, Nastoupil, Loretta, Robertson, Kaye, Sidana, Surbhi, Smedby, Karin E, Sonneveld, Pieter, Tzogani, Kyriaki, van Leeuwen, Flora E, Velikova, Galina, Villa, Diego, Wingard, John R, Seymour, John F, Habermann, Thomas M

“…Remarkable improvements in outcomes for many haematological malignancies have been driven primarily by a proliferation of novel therapeutics over the past two…”
Get full text

Updated Results From the Phase 1/2 MajesTEC-1 Study of Teclistamab, a B-Cell Maturation Antigen x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma by Popat, R, Usmani, SZ, Garfall, A, van de Donk, N, Nahi, H, San-Miguel, JF, Oriol, A, Nooka, A, Martin, T, Rosinol, L, Chari, A, Karlin, L, Benboubker, L, Mateos, MV, Bahlis, N, Moreau, P, Besemer, B, Martinez-Lopez, J, Sidana, S, Pei, LX, Trancucci, D, Verona, R, Girgis, S, Olyslager, Y, Jaffe, M, Uhlar, C, Stephenson, T, Van Rampelbergh, R, Banerjee, A, Goldberg, JD, Kobos, R, Krishnan, A

Get full text

PS1501 QUALITY OF LIFE IN PATIENTS UNDERGOING CHIMERIC ANTIGEN RECEPTOR (CAR) ‐ T CELL THERAPY VS. AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANT FOR HEMATOLOGIC MALIGNANCIES by Sidana, S., Dueck, A., Burtis, M., Griffin, J., Thanarajasingam, G., Warsame, R., Thompson, C., Cheville, A., Gertz, M., Yost, K., Dispenzieri, A., Bisneto, J. Villasboas, Paludo, J., Ansell, S., Rajkumar, S., Bennani, N., Johnston, P., Siddiqui, M., Lin, Y., Kumar, S.

“…Background: CAR (chimeric antigen receptor)‐T cell therapy has shown promise in hematologic malignancies, with some rapid and durable responses. It is now even…”
Get full text